Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia ; volume:35 ; number:9 ; day:8 ; month:7 ; year:2021 ; pages:2735 ; date:9.2021
Leukemia ; 35, Heft 9 (8.7.2021), 2735, 9.2021
- Urheber
-
Werf, Inge van der
Wojtuszkiewicz, Anna
Yao, Huilan
Sciarrillo, Rocco
Meggendorfer, Manja
Hutter, Stephan
Walter, Wencke
Janssen, Jeroen
Kern, Wolfgang
Haferlach, Claudia
Haferlach, Torsten
Jansen, Gerrit
Kaspers, Gertjan J. L.
Groen, Richard
Ossenkoppele, Gert
Cloos, Jacqueline
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-021-01340-z
- URN
-
urn:nbn:de:101:1-2411022106046.473901620594
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Werf, Inge van der
- Wojtuszkiewicz, Anna
- Yao, Huilan
- Sciarrillo, Rocco
- Meggendorfer, Manja
- Hutter, Stephan
- Walter, Wencke
- Janssen, Jeroen
- Kern, Wolfgang
- Haferlach, Claudia
- Haferlach, Torsten
- Jansen, Gerrit
- Kaspers, Gertjan J. L.
- Groen, Richard
- Ossenkoppele, Gert
- Cloos, Jacqueline
- SpringerLink (Online service)
Ähnliche Objekte (12)
RSK1 dependency in FLT3-ITD acute myeloid leukemia
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
RSK1 dependency in FLT3-ITD acute myeloid leukemia
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
RSK1 dependency in FLT3-ITD acute myeloid leukemia
ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation